CHM.CN up 900.00% to C$0.05 on CNQ 11 Mar 2026: high-volume mover, watch liquidity
CHM.CN stock surged 900.00% to C$0.05 on the CNQ in market hours on 11 Mar 2026, up from a previous close of C$0.01. The move makes Waverunner Capital Inc. (CHM.CN) a clear high-volume mover for traders watching small-cap healthcare equities in Canada. Intraday volume was not officially reported, but the stock’s average daily volume is 28,908.00 shares and shares outstanding are 744,233,000.00, keeping liquidity a key risk and opportunity for investors.
CHM.CN stock: what drove the 900.00% move
The price swing for CHM.CN stock reflects a sharp re-rating from C$0.01 to C$0.05 after speculative interest and name change momentum following the June 2024 rebrand to Waverunner Capital Inc. The company profile shows venture capital activity across renewables and biotech, and small float dynamics amplified the move. For company details see Waverunner Capital.
CHM.CN stock: fundamentals and key financial metrics
Waverunner Capital (CHM.CN) reports EPS -0.01 and a negative price/earnings ratio -5.00, indicating no positive earnings. Market cap is C$37,211,650.00 with cash per share C$0.01 and book value per share -C$0.14. The balance sheet shows a low current ratio 0.10, signalling liquidity strain despite a modest debt-to-market-cap ratio 0.01.
CHM.CN stock: technicals, averages and volatility
Technicals show CHM.CN stock trading above its 50-day average C$0.04 (50-day C$0.04) and near its 200-day average C$0.05 (200-day C$0.05). The 12-month range is C$0.05 to C$0.10, and year-to-date momentum includes a 400.00% one-year move in the screener data. Average volume 28,908.00 shares suggests trades can swing price materially when demand spikes.
CHM.CN stock: sector context and market comparison
CHM.CN stock sits in Healthcare, an underperforming sector in Canada with one-week performance at -7.03% and YTD -5.05%. Waverunner’s venture-style holdings differ from larger drug manufacturers, making direct sector comps imperfect. Investors should weigh sector weakness against any company-specific catalysts in renewables or biotech positions.
Meyka AI rates CHM.CN with a score out of 100
Meyka AI rates CHM.CN with a score of 65.06 / 100 and assigns a B grade with a HOLD suggestion. This grade factors in S&P 500 comparison, sector and industry metrics, financial growth, key ratios, forecasts and analyst consensus. Meyka AI, an AI-powered market analysis platform, highlights high volatility, thin liquidity and mixed fundamentals as reasons for the cautious grade.
CHM.CN stock: Meyka AI’s forecast and realistic price targets
Meyka AI’s forecast model projects a short-term reference target of C$0.08 and a 12-month scenario target of C$0.12 versus the current C$0.05, implying an upside of 60.00% and 140.00% respectively. A downside stress case target is C$0.02, implying -60.00% risk. Forecasts are model-based projections and not guarantees. For the company site and filings see Waverunner Capital and for a quick symbol snapshot see CHM.CN image.
Final Thoughts
CHM.CN stock is an extreme small-cap mover after a 900.00% intraday jump to C$0.05 on CNQ on 11 Mar 2026. The surge reflects low base effects, rebranding momentum and speculative flows in a thinly traded equity. Fundamentals show negative earnings (EPS -0.01) and a weak current ratio (0.10), so the rise is powered by sentiment more than operating strength. Meyka AI’s model projects a short-term target of C$0.08 (implied upside 60.00%) and a 12-month target of C$0.12 (implied upside 140.00%) while flagging a downside case to C$0.02 (implied -60.00%). Traders focused on high-volume movers should prioritise liquidity, set tight risk limits, and treat CHM.CN stock as speculative. This analysis appears on Meyka AI’s platform and is designed to inform, not to replace personal research or professional advice.
FAQs
What caused the CHM.CN stock surge today?
The CHM.CN stock surge was driven by low float dynamics, speculative buying and momentum after the company rebranded to Waverunner Capital. Official volume was not reported; average volume is 28,908.00 shares, which can amplify price swings.
What are the main financial risks for CHM.CN stock?
Key risks for CHM.CN stock include negative EPS (-0.01), a weak current ratio (0.10), negative book value per share (-C$0.14) and thin liquidity. These raise dilution and solvency concerns for investors.
What price targets exist for CHM.CN stock?
Meyka AI’s model lists a short-term target C$0.08 and a 12-month target C$0.12, versus current C$0.05. These represent model-based projections and not guarantees; downside case of C$0.02 is possible.
Should I trade CHM.CN stock during market hours?
Trading CHM.CN stock during market hours is possible but risky due to thin liquidity and volatility. Use small position sizes, limit orders and clear stop rules. CHM.CN stock suits speculative traders, not conservative investors.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)